Range
Dist6
XME

XME

State Street SPDR S&P Metals & Mining ETF

$90.42-5.60%
Setup
No setup
Buy Zone
$92.17-$96.78
Sector
Exchange Traded Fund
Industry
Exchange Traded Fund
44
Recommendation
Avoid
Avoid

Too many CANSLIM criteria failing.

XME chart

Loading chart…
Overall Quality44
34
relative strength
45
Weak fund-Q
68
+34% vs avg
25
2/8 checks
91
Exchange Traded Fund

Trade Plan

Avoid
Entry
$92.17
Entry Zone
$92.17-$96.78
Stop / Risk
$84.8
RS Rating
34
Volume confirmed
No
Targets
$110.6 / $115.21

Breakout · IBD Setup

1 ✓ 7 ✗
Entry $92.17–$96.78Stop $84.8Target $110.6 / $115.21
Market regimeRange
Quality44
RS Rating34
Above 50-MA-15.23%
Above 200-MA-19.69%
VolumeWeak
In Buy ZoneNo
Not extendedOK
Invalidation · Close below stop

How this came together

44
MarketRange
SetupNo setup
ConfidenceExperimental · not backtested
Fund-Q45 · Weak
StatusAvoid

Stock Data

52-Week Range86 – 136
Price % Chg YTD-12.73%
Price % Chg 4wk-13.75%
50-Day Avg Vol1.8 Mil
P/E Ratio—
Market Cap$366B
SectorFinancial
IndustryExchange Traded Fund

Company Fundamentals

EPS % Chg (Qtr)—
Sales % Chg (Qtr)—
EPS Growth 5y—
Sales Growth 5y—
Annual ROE—
Gross Margin—
Operating Margin—
Net Margin—
Debt / Equity—

Setup levels

Current price
$90.42
Pivot
$92.17
Distance to buy
-33.4%
52-week range
85.63-135.68

Trigger evidence

No active trigger evidence available.
Financial health checks
0/0

Key metrics

Finviz snapshot · value vs. sector median (≥5 peers)

Annual ROE—
Net margin—
Gross margin—
EPS growth q/q—
Sales growth q/q—
Debt / equity—
lower is better

Business quality

45
GradeWeak
EPS rating50
P/E—
Market cap$366B
IndustryExchange Traded Fund

Technical checks

Über 50-MA
Fail
Über 200-MA
Fail
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Fail
In Kaufzone
Fail
Nicht überextended
Pass
Über 21-EMA
Fail
Volumen gesund
Pass

IBD / source mentions

No recent IBD mention found for this ticker.

Signal history

Added to list
2026-11-04
Trigger date
—
Days on list
2

Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.